TAK logo

TAK Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported41.89%
TAK TTM Operating Income YoY % (-14.79% → 41.89%)
High-resolution chart · PNG

TAK operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
41.8899%
44.5242%
-8.5225%
-44.8605%
70.3488%
60.0458%
30.2978%
25.5478%
-58.3466%
-56.3562%
-21.8868%
-4.0658%
40.174%
6.4362%
-34.6946%
-42.1852%
-38.5631%
-9.5087%
106.6815%
209.0697%
196.5968%
1,121.708%
1,117.0414%
148.3864%
71.6932%
-79.6628%
-88.0494%
-53.5536%
-20.3996%
-15.2282%
-21.7863%
-21.3658%
-26.3884%
55.1252%
44.2233%
25.0397%
-15.4961%
19.1398%
212.4053%
234.6524%
263.3383%
201.217%
-195.1814%
-188.3312%
-193.6557%
-194.2682%
21.5351%
179.3643%
433.6101%
11.9244%
164.0238%
-175.1238%
-117.6149%
-53.7764%
-163.2171%
-26.8593%
-29.245%
-27.8025%
-7.8112%
-7.4199%
-7.2342%
-12.642%
-8.3632%
-15.674%
-14.7904%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.